“Efficacy and Safety of Tralokinumab in US Adults With Moderate-to-Severe Atopic Dermatitis: A Post-Hoc Analysis of ECZTRA3”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): 686–695. Accessed April 3, 2025. https://skin.dermsquared.com/skin/article/view/1871.